Neurocognitive benefits of second-generation antipsychotics versus placebo: Insufficient evidence based on a systematic review

Hiroyoshi Takeuchi, Sadhana Thiyanavadivel, Gagan Fervaha, Gary Remington

Research output: Contribution to journal › Letter

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)274-276
Number of pages3
JournalJournal of Clinical Psychopharmacology
Volume37
Issue number2
DOIs
Publication statusPublished - 2017 Apr 1

Fingerprint

Antipsychotic Agents
Placebos

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Neurocognitive benefits of second-generation antipsychotics versus placebo : Insufficient evidence based on a systematic review. / Takeuchi, Hiroyoshi; Thiyanavadivel, Sadhana; Fervaha, Gagan; Remington, Gary.

In: Journal of Clinical Psychopharmacology, Vol. 37, No. 2, 01.04.2017, p. 274-276.

Research output: Contribution to journal › Letter

Takeuchi, H, Thiyanavadivel, S, Fervaha, G & Remington, G 2017, 'Neurocognitive benefits of second-generation antipsychotics versus placebo: Insufficient evidence based on a systematic review', Journal of Clinical Psychopharmacology, vol. 37, no. 2, pp. 274-276. https://doi.org/10.1097/JCP.0000000000000662
Takeuchi H, Thiyanavadivel S, Fervaha G, Remington G. Neurocognitive benefits of second-generation antipsychotics versus placebo: Insufficient evidence based on a systematic review. Journal of Clinical Psychopharmacology. 2017 Apr 1;37(2):274-276. https://doi.org/10.1097/JCP.0000000000000662
Takeuchi, Hiroyoshi ; Thiyanavadivel, Sadhana ; Fervaha, Gagan ; Remington, Gary. / Neurocognitive benefits of second-generation antipsychotics versus placebo : Insufficient evidence based on a systematic review. In: Journal of Clinical Psychopharmacology. 2017 ; Vol. 37, No. 2. pp. 274-276.
@article{7841f1cd34824c46b8124566448730a9,
title = "Neurocognitive benefits of second-generation antipsychotics versus placebo: Insufficient evidence based on a systematic review",
author = "Hiroyoshi Takeuchi and Sadhana Thiyanavadivel and Gagan Fervaha and Gary Remington",
year = "2017",
month = "4",
day = "1",
doi = "10.1097/JCP.0000000000000662",
language = "English",
volume = "37",
pages = "274--276",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Neurocognitive benefits of second-generation antipsychotics versus placebo

T2 - Insufficient evidence based on a systematic review

AU - Takeuchi, Hiroyoshi

AU - Thiyanavadivel, Sadhana

AU - Fervaha, Gagan

AU - Remington, Gary

PY - 2017/4/1

Y1 - 2017/4/1

UR - http://www.scopus.com/inward/record.url?scp=85010877071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010877071&partnerID=8YFLogxK

U2 - 10.1097/JCP.0000000000000662

DO - 10.1097/JCP.0000000000000662

M3 - Letter

C2 - 28129314

AN - SCOPUS:85010877071

VL - 37

SP - 274

EP - 276

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 2

ER -

Access to Document